| Epidemiology of Diabetes Mellitus and Cardiovascular Disease |
31 |
| Type D Personality as a Risk Factor in Coronary Heart Disease: a Review of Current Evidence |
22 |
| Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment |
17 |
| HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option? |
15 |
| Assessment of Left Atrial Function by Echocardiography: Novel Insights |
15 |
| Long Working Hours and Risk of Cardiovascular Disease |
14 |
| Calcific Aortic Valve Disease: a Developmental Biology Perspective |
13 |
| Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk |
13 |
| Atrial Cardiopathy and Stroke Prevention |
12 |
| Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights |
12 |
| Public Health Policies on E-Cigarettes |
11 |
| Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography |
11 |
| Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure |
11 |
| SGLT2 Inhibitors and Mechanisms of Hypertension |
11 |
| Polygenic Hypercholesterolemia and Cardiovascular Disease Risk |
11 |
| Tumor Necrosis Factor- in Heart Failure: an Updated Review |
11 |
| Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment |
10 |
| Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction |
10 |
| Genetics of Dilated Cardiomyopathy: Clinical Implications |
9 |
| The Autonomic Nervous System and Hypertension: Ethnic Differences and Psychosocial Factors |
8 |
| Infective Endocarditis: Update on Epidemiology, Outcomes, and Management |
8 |
| Paravalvular Leak in Structural Heart Disease |
7 |
| Is Hemispheric Hypoperfusion a Treatable Cause of Cognitive Impairment? |
7 |
| Effect of Alcohol Consumption on Cardiovascular Health |
7 |
| Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy |
7 |
| PET/CT for Diagnosis and Management of Large-Vessel Vasculitis |
7 |
| Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation |
7 |
| Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update |
7 |
| Cardiovascular Consequences of Obstructive Sleep Apnea |
6 |
| Cardiovascular Disease and Hair Cortisol: a Novel Biomarker of Chronic Stress |
6 |
| Cardiomyocyte Proliferation for Therapeutic Regeneration |
6 |
| Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases |
6 |
| Percutaneous Endovascular Aortic Aneurysm Repair for Abdominal Aortic Aneurysm |
6 |
| An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients |
6 |
| What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines |
6 |
| Neural Mechanisms Linking Emotion with Cardiovascular Disease |
6 |
| Diagnosis and Management of Chagas Cardiomyopathy in the United States |
6 |
| The Various Applications of 3D Printing in Cardiovascular Diseases |
6 |
| Machine Meets Biology: a Primer on Artificial Intelligence in Cardiology and Cardiac Imaging |
6 |
| Venous Thromboembolism and Cancer |
6 |
| Transcatheter Pulmonary Valve Replacement: Current State of Art |
6 |
| Genetics of Dilated Cardiomyopathy |
5 |
| The Synergistic Use of Coronary Artery Calcium Imaging and Noninvasive Myocardial Perfusion Imaging for Detecting Subclinical Atherosclerosis and Myocardial Ischemia |
5 |
| The Pivotal Role of Imaging in TAVR Procedures |
5 |
| Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB |
5 |
| Strategies for Minimizing Occupational Radiation Exposure in Cardiac Imaging |
5 |
| Chagas Cardiomyopathy in Latin America Review |
5 |
| Bioprinting Approaches to Engineering Vascularized 3D Cardiac Tissues |
5 |
| Contributions of Interactions Between Lifestyle and Genetics on Coronary Artery Disease Risk |
5 |
| Cardiac Magnetic Resonance Fingerprinting: Technical Developments and Initial Clinical Validation |
5 |
